Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.910
-0.150 (-7.28%)
At close: Aug 13, 2025, 4:00 PM
1.940
+0.030 (1.57%)
After-hours: Aug 13, 2025, 7:52 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $7.08 million as of August 13, 2025. Its market cap has increased by 316.38% in one year.
Market Cap
7.08M
Enterprise Value
1.88M
1-Year Change
316.38%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $7.08M, a decrease of -95.59%. That is a compound annual growth rate of -29.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 6.30M | 186.36% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |